Stay updated with breaking news from Prevention Framework. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. Food and Drug Administration (FDA) recently released draft guidance regarding clinical considerations for studies of medical devices intended to treat opioid use disorder...
Governmental expert meeting for the validation of the study report and guide on civilian possession and licensing of arms in Economic Community of West African States (ECOWAS) region
In the framework of the reduction of illicit trafficking and the fight against the proliferation of Small arms and Light Weapons (SALW), the ECOWAS Commission organized a Governmental Expert Meeting in Lagos, Nigeria from 25th to 27th July 2023. The main objective was to review and validate the draft study…
/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC),...
The U.S. Food and Drug Administration approved the second naloxone nasal spray product available without a prescription.